Cargando…

Correction: Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587945/ https://www.ncbi.nlm.nih.gov/pubmed/26418245 http://dx.doi.org/10.1371/journal.pone.0139818

Ejemplares similares

Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy
por: Meissner, Eric G., et al.
Publicado: (2015)

Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post‐translational modification: prospective placebo‐controlled clinical studies
por: Decalf, Jérémie, et al.
Publicado: (2016)

Effect of interferon-free therapy on cognition in HCV and HCV/HIV infection: A pilot study
por: Kleefeld, Felix, et al.
Publicado: (2017)

Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy
por: Lim, Lucy Y., et al.
Publicado: (2015)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

The performance of soluble CD163 as a non-invasive biomarker of liver damage in chronically HCV and HCV/HIV infected subjects
por: Cairoli, Victoria, et al.
Publicado: (2022)

Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens
por: Tronina, Olga, et al.
Publicado: (2023)

Blockade of Interferon‐γ Normalizes Interferon‐Regulated Gene Expression and Serum CXCL10 Levels in Patients With Systemic Lupus Erythematosus
por: Welcher, Andrew A., et al.
Publicado: (2015)

Interferon-γ and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome
por: Raijmakers, Ruud P. H., et al.
Publicado: (2018)

An Anti-Inflammatory Azaphenothiazine Inhibits Interferon β Expression and CXCL10 Production in KERTr Cells
por: Strzadala, Leon, et al.
Publicado: (2018)

Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
por: Rabquer, Bradley J, et al.
Publicado: (2011)

CXCL10 Decreases GP73 Expression in Hepatoma Cells at the Early Stage of Hepatitis C Virus (HCV) Infection
por: Liu, Yuan, et al.
Publicado: (2013)

Interferon-λ in HCV Infection and Therapy
por: Pagliaccetti, Nicole E., et al.
Publicado: (2010)

Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis
por: Tang, Nelson Leung-Sang, et al.
Publicado: (2009)

CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2016)

Association of circulating CXCL10 and CXCL11 with systemic sclerosis
por: Crescioli, Clara, et al.
Publicado: (2018)

Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients
por: Najmaddini, Hamid, et al.
Publicado: (2014)

CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
por: Yu, Xin, et al.
Publicado: (2022)

CXCL8, CXCL9, and CXCL10 serum levels increase in syphilitic patients with seroresistance
por: Dong, Xiaoyan, et al.
Publicado: (2021)

Recent advances in the anti-HCV mechanisms of interferon
por: Huang, Menghao, et al.
Publicado: (2014)

Role of type I interferon in the bacillus Calmette-Guérin-induced expression of CXCL10 from human monocytes.
por: Méndez Samperio, Patricia, et al.
Publicado: (2004)

Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10
por: Kelly-Scumpia, Kindra M., et al.
Publicado: (2010)

Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction
por: Law, Anna Hing-Yee, et al.
Publicado: (2010)

Experimental coronavirus retinopathy (ECOR): Retinal degeneration susceptible mice have an augmented interferon and chemokine (CXCL9, CXCL10) response early after virus infection
por: Detrick, Barbara, et al.
Publicado: (2008)

Outcomes of Interferon/Ribavirin Therapy in Patients with HCV Defined by Expression of Plasma Soluble Human Leukocyte Antigen-G but Not IL-37
por: Ding, Shi-xiong, et al.
Publicado: (2016)

CXCL4 and CXCL10 Predict Risk of Fatal Cerebral Malaria
por: Wilson, Nana O., et al.
Publicado: (2011)

Platelet Response to Allergens, CXCL10, and CXCL5 in the Context of Asthma
por: Gruba, Sarah, et al.
Publicado: (2022)

HCV Core Protein Induces Chemokine CCL2 and CXCL10 Expression Through NF-κB Signaling Pathway in Macrophages
por: Song, Xiaotian, et al.
Publicado: (2021)

The Effect of Transplantation of Cultured Autologous Melanocytes on CXCL9, CXCL10 and CXCL11 Expressions in Vitiligo
por: Xu, Chen, et al.
Publicado: (2023)

CXCL1, CXCL10 and CXCL12 Chemokines are Variously Expressed in Acute Myeloid Leukemia Patients Prior and Post Bone Marrow Transplantation
por: Yazdani, Bahar, et al.
Publicado: (2021)

Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug Resistance
por: Roche, Bruno, et al.
Publicado: (2015)

Five-Year Follow-Up of Cured HCV Patients under Real-World Interferon-Free Therapy
por: Flisiak, Robert, et al.
Publicado: (2021)

Modifications of liver stiffness and CXCL4, TGF-β1 and HGF are similar in HCV- and HIV/HCV-infected patients after DAAs
por: Márquez-Coello, Mercedes, et al.
Publicado: (2021)

Regulation of the Interferon Response by lncRNAs in HCV Infection
por: Valadkhan, Saba, et al.
Publicado: (2018)

Jumonji: Welcome to the World of Interferon Signaling in Alcohol and HCV
por: Moghe, Akshata, et al.
Publicado: (2017)

Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies
por: Proost, Paul, et al.
Publicado: (2006)

MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis
por: Tworek, Damian, et al.
Publicado: (2013)

CXCL10 and IL‐6: Markers of two different forms of intra‐amniotic inflammation in preterm labor
por: Romero, Roberto, et al.
Publicado: (2017)

IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
por: Maruoka, Hayato, et al.
Publicado: (2013)

Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life
por: Real, Luis M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7bon3dat7ie3o2r62hbhcretb8